7.00pm to 8.30pm, Tuesday 4 February
Queen Mary University of London, Perrin Lecture theatre, Blizard Institute, 4 Newark St, London E1 2AT
This event has already taken place
How are genes, proteins, and smart phones shaping the way we tackle disease? Is wearable technology such as the Apple Watch, which can monitor people for signs of stroke/heart attack and alert health services automatically, the future? What are the emerging ethical issues around digital health data, different risk profiles, and can they be overcome? What is the future of screening, and what are the decision trees in allocating scarce resource?
PLEASE NOTE: This event will take place at Queen Mary University of London, at the Perrin Lecture Theatre in the Blizard Institute in Whitechapel. The address is 4 Newark St, Whitechapel, London E1 2AT.
Rebecca Fitzgerald is a medical researcher whose work focuses on the early detection and treatment of oesophageal cancers. She is a tenured Professor of Cancer Prevention and Program Leader at the Medical Research Council Cancer Unit of the University of Cambridge.
Alastair Denniston is a consultant ophthalmologist (eye specialist) at University Hospitals Birmingham leading research into the use of health data research and artificial intelligence to improve patient care in the ‘real world’. He is Professor at the University of Birmingham, and part of the Biomedical Research Centre for Ophthalmology at Moorfields Eye Hospital/UCL.
Leila Luheshi is the Associate Director for Clinical and Translational Research at Oxford Nanpore Technologies Ltd. She was previously Programme Lead (Science) at the PHG Foundation, where she was responsible for the delivery of the scientific expertise and analysis that underpins the work of the Foundation. She also contributed to the development of their strategic partnerships with other organisations who have an interest in science and health policy.
Your chair for the evening is Sir Harpal Kumar. Harpal is the Head of Johnson & Johnson Innovation EMEA, based at the Innovation Center in London. Before joining Johnson & Johnson Innovation, Harpal’s career has been largely focused on improving healthcare outcomes through innovation. He spent 15 years with Cancer Research UK (CRUK) and served as the organisation’s Chief Executive from April 2007 until June 2018. Prior to this, he was Chief Operating Officer & Executive Director of Development at CRUK and served as Chief Executive of Cancer Research Technology (a subsidiary of CRUK).
The doors will open at approximately 6.30pm, with a prompt start at 7.00pm.
After the event, audience members are invited to visit Centre of the Cell. Centre of the Cell is an award-winning science education centre based within the Blizard Institute at Queen Mary University of London. Centre of the Cell’s unique interactive exhibition, STEM Pod, will be open from 8:30pm until 9:15pm for attendees to explore.
The Perrin Lecture theatre is fully accessible. You can find out more information on this page.
Seating is usually unreserved for our events. If you and your group require seating reservations, please do let us know by email and we’ll be more than happy to help. Email: email@example.com
Carers can receive a free ticket to an event by emailing firstname.lastname@example.org
Benefit from free and better than half-price tickets, special offers and access to the CHRISTMAS LECTURES ticket ballot.